DoP re-invites applications to manufacture erythromycin thiocyanate under PLI scheme
The Department of Pharmaceuticals (DoP) has re-invited applications from eligible applicants to manufacture fermentation based key starting material/drug intermediate erythromycin thiocyanate under the production linked incentive (PLI) scheme for promotion of domestic manufacturing of 41 KSMs/DIs/APIs
DoP Re-invites Applications To Manufacture Erythro | 07/07/2021 | By Darshana | 266
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy